Predicting Antimicrobial Resistance from Genomic Data: Methods, Algorithms, and Clinical Translation

Abstract

The prediction of antimicrobial resistance (AMR) from genomic data represents a paradigm shift in veterinary clinical microbiology. By leveraging whole-genome sequencing and advanced computational frameworks, it is now possible to infer resistance phenotypes directly from bacterial DNA sequences. This review synthesizes current approaches spanning data generation, feature engineering, machine learning model architectures, validation strategies, and emerging systems-level modeling. Drawing on recent advances in pangenomics, graph neural networks, and explainable artificial intelligence, we examine how these tools are being applied to key veterinary pathogens including Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, and Salmonella enterica. Particular attention is given to challenges such as population structure bias, gene copy number effects, and the need for harmonized bioinformatics workflows.

1. Introduction

Antimicrobial resistance constitutes a growing threat to both human and veterinary medicine. In livestock and companion animal practice, the emergence of multidrug-resistant organisms complicates therapeutic management of conditions ranging from colibacillosis in poultry to mastitis in dairy cattle and pyoderma in dogs. Traditional culture-based susceptibility testing, while definitive, requires 48 to 72 hours for results and cannot capture the full genetic repertoire of resistance determinants harbored by a bacterial population.

Genomic prediction of AMR aims to bridge this gap by correlating DNA sequence features with phenotypic resistance profiles. The approach relies on the principle that most acquired resistance mechanisms have a genetic basis: point mutations in target genes, acquisition of resistance genes via horizontal gene transfer, or alterations in gene expression mediated by regulatory elements. By training computational models on curated datasets of sequenced isolates with matched susceptibility data, algorithms can learn to predict resistance for unseen genomes with varying degrees of accuracy.

The field has advanced rapidly owing to the decreasing cost of high-throughput sequencing, maturation of bioinformatics annotation pipelines, and the application of sophisticated machine learning methods. This review provides a comprehensive technical overview of the genomic AMR prediction pipeline, from raw sequence data to clinically actionable inference.

2. Data Generation and Curation

2.1 Sequencing Technologies and Assembly

The foundation of genomic AMR prediction is high-quality sequence data. Short-read sequencing from high-throughput platforms remains the most common approach, generating reads of 75 to 300 base pairs with high base-call accuracy. For veterinary surveillance, this approach provides sufficient coverage depth (typically 50x to 100x) to detect single nucleotide polymorphisms and gene presence-absence variation. Long-read sequencing technologies produce reads exceeding 10 kilobases, enabling the resolution of repetitive elements, plasmid structures, and genomic rearrangements that may carry resistance genes. Hybrid assemblies combining both read types offer the most complete genomic reconstructions.

Quality control steps include read trimming, adapter removal, and assessment of sequencing depth. For downstream prediction, draft assemblies are typically annotated using curated databases such as ResFinder, CARD (Comprehensive Antibiotic Resistance Database), and NCBI AMRFinderPlus. The accuracy of gene detection depends on the completeness of these databases and the thresholds used for sequence identity and coverage.

2.2 Phenotypic Data Standardization

Training predictive models requires paired genotype-phenotype data. Minimum inhibitory concentration (MIC) values determined by broth microdilution or agar dilution serve as the reference standard. For binary classification (resistant versus susceptible), clinical breakpoints defined by committees such as the Clinical and Laboratory Standards Institute (CLSI) or the European Committee on Antimicrobial Susceptibility Testing (EUCAST) are applied. However, breakpoints may differ between human and veterinary medicine, necessitating careful harmonization when training models on datasets that include both isolate types.

The importance of standardized phenotypic data is underscored by work on Escherichia coli from foodborne sources [1] and from sepsis cases [29], where consistent MIC determination protocols were critical for model performance.

3. Feature Engineering for Prediction

3.1 Gene Presence-Absence and Point Mutations

The simplest feature representation for AMR prediction is the binary presence or absence of known resistance genes. This approach works well when resistance is conferred by acquired genes such as beta-lactamases (blaCTX-M, blaTEM), aminoglycoside-modifying enzymes (aac, aph), or tetracycline efflux pumps (tet). However, many resistance phenotypes arise from point mutations in chromosomal genes. For example, fluoroquinolone resistance in Escherichia coli frequently involves mutations in gyrA and parC, while methicillin resistance in Staphylococcus aureus depends on the mecA gene. These features are typically extracted by aligning sequencing reads or assembled contigs against reference databases.

3.2 K-mer Based Representations

K-mer approaches bypass gene annotation entirely by representing genomes as counts of all possible DNA subsequences of length k. This method can capture both known and novel resistance-associated sequence patterns, including regulatory regions and non-coding variants. Random forest and gradient boosting models trained on k-mer features have shown comparable or superior performance to gene-based models for several pathogen-antibiotic combinations [2, 3]. The trade-off is interpretability: while k-mers may be highly predictive, mapping them back to biological mechanisms requires additional computational steps.

3.3 Pangenome and Accessory Genome Features

Many resistance genes reside on mobile genetic elements within the accessory genome. A pangenome-aware approach constructs features from the union of all genes present across a set of isolates, including core genes (present in all isolates) and accessory genes (present in a subset). The pangenome-based machine learning framework developed for foodborne Escherichia coli [1] demonstrated that accessory genome features substantially improved prediction accuracy for drugs where resistance is plasmid-mediated. The PanARGMiner framework specifically selects resistance-associated genes from pangenomic datasets by integrating multiple feature importance metrics [4].

3.4 Copy Number Variation

Gene copy number is increasingly recognized as an important predictor of AMR. For Staphylococcus aureus, copy number features extracted from whole-genome sequencing data generalized better across populations than SNP-based features [5]. This finding is mechanistically plausible: increased copy number of beta-lactamase genes or efflux pump components can elevate resistance levels above clinical breakpoints even in the absence of sequence-level mutations.

3.5 Structural Variants and Mobile Genetic Elements

Beyond gene content, the genomic context of resistance genes influences expression and transmission. Features capturing the integration site, flanking insertion sequences, and plasmid replicon type provide additional predictive power. Graph-based representations that encode the relational structure of genomic elements, such as the AMR-GNN framework, explicitly model these interactions [6].

4. Machine Learning Model Architectures

4.1 Traditional Classifiers

Logistic regression, random forests, and gradient boosted trees (XGBoost, LightGBM) remain widely used for AMR prediction due to their interpretability and robustness with tabular feature data. For Escherichia coli, random forest classifiers trained on SNP and gene presence-absence features achieved area under the receiver operating characteristic curve (AUC-ROC) values exceeding 0.90 for several antibiotic classes [2, 7]. Similarly, random forest models applied to Klebsiella pneumoniae bloodstream infections demonstrated strong performance for predicting multidrug resistance [8].

4.2 Deep Learning Approaches

Deep neural networks can capture non-linear interactions between features that traditional models miss. Convolutional neural networks applied to k-mer count matrices or one-hot encoded sequence representations have been explored for AMR prediction. However, deep learning models require large training datasets and are prone to overfitting when sample sizes are limited. The integration of multi-omics data within deep learning frameworks is an active area of research [9, 10].

4.3 Graph Neural Networks

The AMR-GNN framework represents a significant methodological advance by encoding genomic features as a graph [6]. In this representation, nodes correspond to genes or genomic elements, and edges capture physical proximity, co-occurrence, or known regulatory interactions. Message passing between nodes allows the model to learn contextual dependencies, such as the effect of a promoter mutation on the expression of a downstream resistance gene. This approach achieved state-of-the-art performance on benchmark datasets for Escherichia coli and Klebsiella pneumoniae.

4.4 Ensemble and Interpretable Models

Ensemble methods combine multiple base classifiers to improve robustness. The interpretable ensemble learning approach applied to Treponema denticola [33] used expert-defined feature sets to guide model training while maintaining transparency. Similarly, rule-based classifiers derived from machine learning can provide explicit decision criteria for clinical use, as demonstrated for Staphylococcus aureus [35].

5. Workflow for Genomic AMR Prediction

The following workflow summarizes the key steps from sample collection to resistance phenotype prediction.

graph TD
    A[Clinical Isolate], > B[DNA Extraction and Sequencing]
    B, > C{Quality Control}
    C, >|Pass| D[Read Processing and Assembly]
    C, >|Fail| B
    D, > E[Feature Extraction]
    E, > E1[Gene Presence-Absence]
    E, > E2[Point Mutation Detection]
    E, > E3[K-mer Profiling]
    E, > E4[Copy Number Estimation]
    E, > E5[Structural Variant Calling]
    E1, > F[Feature Matrix Construction]
    E2, > F
    E3, > F
    E4, > F
    E5, > F
    F, > G[Trained ML Model]
    G, > H[Resistance Phenotype Prediction]
    H, > I[Clinical Decision Support]
    I, > J[Antimicrobial Therapy Selection]
    
    subgraph Training Phase
        K[Paired Genotype-Phenotype Dataset]
        K, > L[Feature Engineering]
        L, > M[Model Training and Tuning]
        M, > G
    end
    
    style A fill:#f9f,stroke:#333,stroke-width:2px
    style H fill:#9cf,stroke:#333,stroke-width:2px
    style J fill:#9cf,stroke:#333,stroke-width:2px

6. Validation Strategies and Performance Metrics

6.1 Internal Validation

Standard internal validation approaches include k-fold cross-validation, leave-one-out cross-validation, and stratified train-test splits. For AMR prediction, stratified splitting by phylogenetic lineage or serotype is recommended to assess generalization across bacterial populations.

6.2 External Validation

External validation on independently collected isolates is essential for estimating real-world performance. Studies that validated models on geographically or temporally distinct collections often report decreased accuracy compared to internal validation [11]. This performance drop is attributable to differences in population structure, resistance gene prevalence, and the emergence of novel resistance mechanisms.

6.3 Population Structure Bias

A critical finding is that bacterial population structure can confound machine learning predictions [11]. If training and test sets share close phylogenetic relationships, models may learn lineage-specific associations rather than causal resistance determinants. Correcting for population structure through inclusion of phylogenetic principal components or using mixed-effects models is recommended.

6.4 Performance Metrics

Standard metrics for binary classification include accuracy, sensitivity, specificity, positive predictive value, negative predictive value, and AUC-ROC. For multiclass or multilabel prediction (predicting resistance to multiple antibiotics simultaneously), macro-averaged and micro-averaged metrics are used. The major error category in most studies is false susceptible predictions (resistant isolates misclassified as susceptible), which carries greater clinical risk than false resistant predictions.

7. Applications in Veterinary Pathogens

7.1 Escherichia coli

Escherichia coli remains the most extensively studied species for genomic AMR prediction in veterinary contexts. Pangenome-based interpretable frameworks have been applied to foodborne isolates [1], and integrative modular approaches have been developed for predicting accessory genome functions in serotype O157:H7 [12]. Single-cell genomic profiling has revealed within-host resistance heterogeneity in environmental isolates [13], highlighting the importance of population-level sampling.

7.2 Klebsiella pneumoniae

Evolutionary inference approaches have resolved the natural histories and predicted resistance pathways of Klebsiella pneumoniae [14]. Machine learning models trained on whole-genome sequencing data have achieved strong performance for predicting resistance to multiple drug classes, including carbapenems and third-generation cephalosporins [3]. Systematic reviews have evaluated the clinical microbiology applications of artificial intelligence for this pathogen [15].

7.3 Staphylococcus aureus

Copy number features demonstrate superior generalization compared to SNPs for Staphylococcus aureus [5]. Machine learning classifiers based on whole-genome sequencing data have been developed for predicting resistance to methicillin, vancomycin, and other agents [30]. Minimal feature sets selected by machine learning have driven highly accurate rule-based predictions from metagenomic sequencing data [35].

7.4 Salmonella enterica

Genomic prediction of AMR in nontyphoidal Salmonella has been explored using whole-genome-based machine learning approaches [32]. For Salmonella Typhi, the Typhi Mykrobe tool provides fast and accurate lineage identification and resistance genotyping directly from sequence reads [16].

7.5 Campylobacter spp.

Machine learning prediction of multidrug resistance in swine-derived Campylobacter species has been performed using surveillance data, demonstrating the utility of these approaches in food animal production systems [17].

7.6 Agricultural and Environmental Isolates

Predictions based on genomic data for bacterial strains of agricultural interest have been reviewed, encompassing plant-associated bacteria and soil isolates [18]. Surveillance studies in regions with high AMR burden, such as India, have provided multi-species genomic landscapes that inform prediction model development [19].

8. Challenges and Limitations

8.1 Data Heterogeneity

One of the principal barriers to clinical deployment is the heterogeneity of training data. Different studies use different sequencing platforms, assembly pipelines, annotation databases, and phenotypic testing methods. Harmonized workflows such as cAMRah address this need by providing scalable and portable pipelines for resistance gene prediction [20]. The EUCAST subcommittee has provided updated guidance on the role of whole-genome sequencing in susceptibility prediction [21].

8.2 Unknown Resistance Mechanisms

Current models cannot predict resistance mediated by mechanisms absent from the training data. This is particularly problematic for emerging resistance phenotypes or for pathogens with poorly characterized resistance gene repertoires. Comparative assessment of annotation tools has revealed critical knowledge gaps in species such as Klebsiella pneumoniae [22].

8.3 Quantitative Resistance Prediction

Most models predict binary resistance categories rather than MIC values. Predicting quantitative MICs is more challenging but clinically valuable, as it enables precise dose adjustment. The ASAP-ML framework represents one approach to antibiogram prediction using machine learning [23].

8.4 Interpretability

Black-box models, particularly deep neural networks, provide limited insight into the biological basis of their predictions. Explainable AI methods, including SHAP (SHapley Additive exPlanations) and LIME (Local Interpretable Model-agnostic Explanations), are increasingly applied to identify the genomic features driving predictions [1, 10].

9. Emerging Directions

9.1 Multi-Omics Integration

Integrating genomic data with transcriptomic, proteomic, and metabolomic profiles promises to capture resistance mechanisms operating at multiple biological levels. AI-driven frameworks for multi-omics analysis in AMR are being developed [9], with applications to both target discovery and clinical translation [24].

9.2 Foundation Models and Large Language Models

Recent advances in foundation artificial intelligence systems, including large language models adapted for biological sequences, offer the potential to predict resistance from raw sequence data without explicit feature engineering [10]. These models learn contextual representations of DNA sequences and can be fine-tuned for specific prediction tasks.

9.3 Point-of-Care Prediction

The integration of genomic prediction with rapid sequencing technologies could enable point-of-care resistance profiling. Proof-of-concept studies using genomic and epidemiologic data for Neisseria gonorrhoeae [31] demonstrate the feasibility of near-real-time prediction, though challenges remain for veterinary deployment in field settings.

9.4 AI-Driven Target Discovery

Computational frameworks integrating omics-based and systems-level modeling are being applied to ESKAPE pathogens for next-generation target discovery [24]. These approaches identify novel vulnerabilities in resistant bacteria that could inform the development of new antimicrobial agents.

10. Conclusions

Genomic prediction of antimicrobial resistance has matured from proof-of-concept studies to robust, validated computational frameworks. The integration of whole-genome sequencing with machine learning offers the potential to accelerate resistance detection in veterinary clinical microbiology, enabling more timely and targeted antimicrobial therapy. Key remaining challenges include standardization of data generation and annotation, mitigation of population structure bias, model interpretability, and the prediction of resistance conferred by unknown or poorly characterized mechanisms.

For veterinary applications, the development of species-specific models trained on clinically relevant isolate collections is essential. The continued expansion of publicly available genomic and phenotypic data, coupled with advances in explainable artificial intelligence and multi-omics integration, will drive the next generation of prediction tools.

References

[1] Ren J, Xu Y, Wang Z, et al. Pangenome-based interpretable machine learning framework for predicting antimicrobial resistance in foodborne Escherichia coli. Food Res Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42270222/

[2] Wan F, Tong W, Wu W, et al. Utilizing whole genome sequencing data for machine learning driven prediction of antibiotic resistance in Escherichia coli. Front Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42131209/

[3] Jia X, Zhang J, Chen J, et al. Machine learning-based prediction of multi-level antimicrobial resistance in Klebsiella pneumoniae using whole-genome sequencing data. Int J Antimicrob Agents. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41997433/

[4] Chen YC, Yang MR, Wu YW. PanARGMiner (Pan-Genomic Antimicrobial Resistance Gene Miner): An advanced feature selection framework for extracting key resistance genes from pan-genomic datasets. Comput Struct Biotechnol J. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41395110/

[5] Fistarol BF, Gervasio JD, Szöllősi GJ. Gene copy-number features generalize better than SNPs for antimicrobial resistance prediction in Staphylococcus aureus. NPJ Antimicrob Resist. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41402414/

[6] Nguyen HA, Peleg AY, Wisniewski JA, et al. AMR-GNN: a multi-representation graph neural network framework to enable genomic antimicrobial resistance prediction. Nat Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41792137/

[7] Moat J, Zovoilis A, Steinkey R, et al. Machine learning methods to identify markers and predict antimicrobial resistance in Escherichia coli. Can J Microbiol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41151064/

[8] Wang N, Hu A, Wang Z, et al. Antimicrobial resistance analysis of Klebsiella pneumoniae bloodstream infections based on a random forest algorithm: a longitudinal study based on data from tertiary hospitals in China from 2012 to 2023. Int Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41496730/

[9] Singhal N, Kumar M. AI in multi-omics analysis in AMR. Prog Mol Biol Transl Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42173634/

[10] Hossain E, Yousefi N. Computational paradigms for antimicrobial resistance prediction: integrating multi-omics, structural modeling, and foundation artificial intelligence systems. Brief Bioinform. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42108632/

[11] Yu Y, Wheeler NE, Barquist L. Biased sampling driven by bacterial population structure confounds machine learning prediction of antimicrobial resistance. PLoS Biol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41401143/

[12] Gambushe SM, Zishiri OT. Integrative Modular, Network-Based, and Machine Learning Framework for Predicting Accessory Genome Functions and Virulence in Escherichia coli O157:H7. Microbiologyopen. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42272257/

[13] Furuya R, Nishikawa Y, Ota Y, et al. Single-cell genomic profiling of antimicrobial resistance in Escherichia coli from the Densu River, Ghana. Front Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42112445/

[14] Aga ONL, Moyo SJ, Manyahi J, et al. Evolutionary inference reveals global natural histories and predicted pathways of antimicrobial resistance in Klebsiella pneumoniae. PLoS Biol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42284356/

[15] Aggarwal RV, Shah N, Wong JJE, et al. Artificial Intelligence for Antimicrobial Resistance Detection and Prediction in Klebsiella pneumoniae: A Systematic Review of Clinical Microbiology Applications. Infect Drug Resist. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42261281/

[16] Ingle DJ, Hawkey J, Hunt M, et al. Typhi Mykrobe: fast and accurate lineage identification and antimicrobial resistance genotyping directly from sequence reads for the typhoid fever agent Salmonella Typhi. Genome Med. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41327441/

[17] Sodagari HR, Ghasemi M, Varga C, et al. Machine Learning Prediction of Multidrug Resistance in Swine-Derived Campylobacter spp. Using United States Antimicrobial Resistance Surveillance Data (2013-2023). Vet Sci. 202

[18] Pajuelo E, Medina-Rodríguez M, Flores-Duarte NJ, et al. Antimicrobial Resistance in Bacterial Strains of Agricultural Interest: Predictions Based on Genomic Data. Antibiotics (Basel). 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41594052/

[19] Gheewalla N, Karthikeyan V, Jadhav Y, et al. Genomic landscape of antimicrobial resistance in India: findings from a multi-species surveillance study. NPJ Antimicrob Resist. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41699191/

[20] Matute DL, Clarke TH, LaPointe AR, et al. cAMRah: a scalable and portable workflow for harmonized antimicrobial resistance gene prediction from bacterial genomes. Bioinform Adv. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41710351/

[21] Samuelsen Ø, López-Causapé C, Aarestrup FM, et al. The role of whole genome sequencing in antimicrobial susceptibility prediction of bacteria: 2025 update from the European Committee on Antimicrobial Susceptibility Testing Subcommittee. Clin Microbiol Infect. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42142806/

[22] Kordova K, Collins C, Parkhill J. Comparative assessment of annotation tools reveals critical antimicrobial resistance knowledge gaps in Klebsiella pneumoniae. Sci Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41254078/

[23] Topcu D, Akcapinar Sezer E. ASAP-ML: Antibiotic Susceptibility and Antibiogram Prediction With Machine Learning Methods. IEEE Trans Comput Biol Bioinform. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41247898/

[24] Chines E, Tempesta AA, Boscarelli L, et al. Next-Generation Target Discovery in ESKAPE Pathogens: An AI-Driven Framework from Omics-Based to Systems-Level Modeling and Clinical Translation. Antibiotics (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42192691/

[25] Singh R, Lin YW, Zhao J, et al. Artificial intelligence and machine learning in antimicrobial discovery, resistance prediction, and precision therapy. Int J Antimicrob Agents. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41520708/

[26] Shrivastava R, Sharma K, Mishra S, et al. Integrative machine learning approaches with genomic data for predicting antitubercular drug resistance: A systematic review and meta-analysis. J Glob Antimicrob Resist. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41391586/

[27] Ghosh A, Brenner EP, Vang CK, et al. From sequence to signature: Machine learning uncovers multiscale feature landscapes that predict AMR across ESKAPE pathogens. bioRxiv. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41279520/